Noncomplement fixing, IgG4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid.
This study characterized the specific reactivity, IgG subclass, and complement fixing ability of anti-laminin-5 IgG from 12 patients with anti-epiligrin cicatricial pemphigoid. Circulating IgG from all patients bound the dermal side of 1 M NaCl split skin, immunoprecipitated laminin-5 produced by biosynthetically radiolabeled human keratinocytes, and (in 10 of 12 cases) immunoblotted the laminin-alpha3 subunit. Analysis of the distribution of IgG subclasses in these patients' circulating anti-laminin-5 autoantibodies by semiquantitative indirect immunofluorescence microscopy using the HP series of subclass-specific monoclonal antibodies revealed: (i) IgG4 predominant autoantibodies in seven of 11 sera; (ii) IgG1 and IgG2 at substantially lower levels in a smaller number of sera; and (iii) no specific IgG3 anti-laminin-5 autoantibodies in any patients. The same IgG4-dominant profile of anti-laminin-5 autoantibodies was found in enzyme-linked immunosorbent assay studies of purified human laminin 5. Direct immunofluorescence microscopy of six skin biopsies from three patients found that IgG4 was also the predominant subclass of IgG in epidermal basement membranes in situ. Consistent with these findings, sera from 11 of 11 patients with anti-laminin-5 IgG autoantibodies did not fix C3 to epidermal basement membranes in vitro. These immunochemical studies suggest that complement activation does not play a major role in the pathophysiology of this disease and that subepidermal blisters in these patients may develop via a direct effect of anti-laminin-5 IgG itself.
Hsu
R
R
Dermatology Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1908, U.S.A.
Lazarova
Z
Z
Yee
C
C
Yancey
K B
KB
D001323:Autoantibodies / Q000032:analysis* / Q000276:immunology*; D001485:Basement Membrane / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000032:analysis / Q000276:immunology*; D003168:Complement Fixation Tests; D003165:Complement System Proteins / Q000276:immunology*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis* / Q000276:immunology; D007797:Laminin / Q000276:immunology; D010390:Pemphigoid, Benign Mucous Membrane / Q000276:immunology*; D011233:Precipitin Tests; D011247:Pregnancy; D000097794:Kalinin
D001323:Autoantibodies; D015815:Cell Adhesion Molecules; D003165:Complement System Proteins; D007074:Immunoglobulin G; D007797:Laminin; D000097794:Kalinin